ERBB2 and breast cancer: No data about a significant correlation between CD34_CAFs_D, tumor stroma vessels, and invasion is available at this time in the literature for BC, and thus, our findings will need further studies for a complete characterization of CD34_CAFs’ impact on therapy and prognosis for the HER2 subtype.